Roscovitine and purvalanol A effectively reverse anthracycline resistance mediated by the activity of aldo-keto reductase 1C3 (AKR1C3): A promising therapeutic target for cancer treatment
2015 ◽
Vol 78
(11)
◽
pp. 2666-2674
◽
2013 ◽
Vol 4
(10)
◽
pp. e838-e838
◽
2014 ◽
Vol 18
(4)
◽
pp. 403-414
◽
2017 ◽
Vol 11
(7)
◽
pp. 673-682
◽